View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200 / Pemetrexed 500, Non-Small Cell Lung Cancer, Maintenance
Protocol-ID: 2636 V1.0 (Mini), TISL200/PEME500, NSCLC, maint.Indication(s)
- Lung Carcinoma, Non-Small Cell (non-squamous); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.06.2024